NCT05910164View on ClinicalTrials.gov

Patient Preference Between a Prefilled Syringe or a Prefilled Pen Device for Administration of Pegfilgrastim

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 9, 2023

Primary Completion Date

September 9, 2023

Study Completion Date

October 9, 2024

Conditions
Patient PreferenceFebrile Neutropenia, Drug-InducedPatient Satisfaction
Interventions
DEVICE

PELGRAZ prefilled syringe or PELGRAZ prefilled pen

PELGRAZ prefilled syringe or PELGRAZ prefilled pen https://www.ema.europa.eu/en/medicines/human/EPAR/pelgraz

Trial Locations (1)

92300

Institut Rafael, Levallois-Perret

Sponsors

Lead Sponsor

Institut Rafael
All Listed Sponsors
lead

Institut Rafael

OTHER